Solarvest BioEnergy (SVS) Stock Price, News & Analysis

Company Overview

Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products. It provides human nutrition products, including omega-3; clean energy production system that enables for continuous hydrogen production; and active ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. Solarvest BioEnergy Inc. has a collaborative research and development agreement with FSD Pharma Inc. to produce cannabidiol (CBD), Cannabigerol (CBG), and tetrahydrocannabinol (THC) programs. The company was incorporated in 2005 and is based in Vancouver, Canada.

Key Stats

• Today's Range: C$0.02 to C$0.03
• 50-Day Range: C$0.03 to C$0.03
• 52-Week Range: C$0.01 to C$0.14
• Volume: 3,159 shs
• Average Volume: 77,594 shs
• Market Capitalization: C$1.52 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SVS Stock Analysis - Frequently Asked Questions

How have SVS shares performed this year?

Solarvest BioEnergy's stock was trading at C$0.03 at the start of the year. Since then, SVS shares have increased by 0.0% and is now trading at C$0.03.
View the best growth stocks for 2025 here.

How do I buy shares of Solarvest BioEnergy?

Shares of SVS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Solarvest BioEnergy own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Solarvest BioEnergy investors own include FSD Pharma (HUGE), Nemaska Lithium (NMX), Intercept Pharmaceuticals (ICPT), Sernova (SVA), Routemaster Capital Inc. (RM.V) (RM), IGEN Networks (IGEN) and Clean Energy Pathways (CPWY).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: CVE:SVS
• CIK: N/A
• Web: www.solarvest.ca
• Phone: +1-604-6843323
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($0.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$2.26 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -143.12%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: 0.02

Sales & Book Value

• Annual Sales: C$740.00
• Price / Sales: 2,052.70
• Cash Flow: C$0.00 per share
• Price / Cash Flow: 55.00
• Book Value: C($0.10) per share
• Price / Book: -0.25

Miscellaneous

• Outstanding Shares: 60,760,000
• Free Float: N/A
• Market Cap: C$1.52 million
• Optionable: Not Optionable
• Beta: 1.50